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Abstract
Bioluminescence is the ability of naturally occurring organisms to emit light. Many
instances of bioluminescence have been identified ranging from fireflies to bacteria. The
protein responsible for bioluminescence in all of these organisms is luciferase. The exact
function and structure of this protein are still unknown to this day. This project aims at
better understanding luciferase as well as enhancing its bioluminescent properties. In
order to work with luciferase, we had to isolate all of the genes necessary for
bioluminescence. The six genes necessary for bioluminescence are Lux A,B,C,D,E,G.
We isolated each of these genes from original bacterial DNA. We then put these genes
back together into our own synthesized plasmids through a method called Gibson
Assembly. These plasmids were then mutated through a process called site-directed
mutagenesis. The mutated plasmids were introduced to E.coli cells and mutated protein
were produced and screened for enhanced bioluminescent properties.
We were able to successfully isolate all of the DNA fragments necessary for
bioluminescence. We were then able to successfully create one of the two plasmids
necessary for bioluminescence. The successful creation of this plasmid shows that we
were able to successfully isolate and combine the DNA fragments. By shifting a few
small experimental parameters we should be able to complete our second plasmid and
achieve bioluminescence, and move onto mutating the DNA. Luciferase doesn’t have
many applications in today’s world because it remains so understudied. By mutating
luciferase, we hope to shed some light on this protein and allow it to be widely used. One
possible application is being explored by a company called the Glowing Plant Project,
located in San Francisco. They are using the luciferase and inserting it into plant genomes
to create glow in the dark plants. These have some amazing promise not just aesthetically
in our gardens but also as a potential light source for third world and developing
countries.
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Introduction
Bioluminescence is a term used to describe natural light emission from living organisms.
These organisms include, but are not limited to the Firefly, Fungi, and Bacteria. All
bioluminescent organisms exhibit a very similar chemical reaction to achieve light
emission. This reaction involves a variety of molecules that are acted upon by a protein
called luciferase. Luciferase oxidizes the molecules, and in the process releases a photon
of light as seen in Figure 1. The exact function and chemical properties of luciferase are
relatively unknown; this project aims to shed some light on the bioluminescent properties
of luciferase.
FMNH2 + O2 + RCHO → FMN + RCOOH + H2O + light
Equation 1. The chemical reaction of bacterial luciferase.

Protein engineering is an extremely recent field of science. The importance of proteins
was only realized in the last few decades. Since then, scientists have been trying to figure
out ways to study proteins and how they work. One of the most successful methods used
to study protein function is a technique called site directed mutagenesis. This technique
takes advantage of the central dogma of biology. The central dogma of biology is a term
used to describe the production of proteins from a specific DNA sequence.
Fundamentally, a specific sequence of DNA corresponds to a specific sequence of amino
acids. Every protein is therefore made up of a combination of20 known amino acids. The
5
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exact DNA sequences are used by the cell as a sort of “blueprint” to produce a sequence
of amino acids, the building blocks of proteins, which give proteinstheir unique
properties and function as can be seen in Figure 1. Any changes in the DNA sequence
leads to an altered amino acid sequence, corresponding to a change in protein function.
Novel techniques allow researchers to change single amino acids within a protein. Sitedirected mutagenesis involves changing single amino acids by altering the DNA and
studying the resulting protein function. Using this method it is possible to map out which
amino acids give rise to specific protein properties. Through lengthy experimentation, it
is possible to check each and every amino acid of a protein and study the resulting protein
function. This gives researchers a way to infer exactly which amino acids are critical to
protein function. These critical amino acids are described as the “active site” of the
protein and have the largest impact on the function of the protein. Unfortunately, the
active site of luciferase is still unknown. Our project will use site directed mutagenesis to
find mutants of luciferase with slightly altered functions. We will be using the bacterial
luciferase responsible for the bioluminescence in deep-sea squids (Vibrio fischeri). Even
though it is still under research, luciferase is already widely used in whole animal
imaging, as a reporter gene, and as a monitor in bioreactors.

Figure 1: The central dogma of Biology. DNA is transcribed into RNA, which is translated
into amino acids. Amino acids are the building blocks of all proteins
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Scientific
A protein with a similar function to luciferase, Green Fluorescent Protein (GFP) has been
extensively studied and is widely used in molecular biology, while luciferase remains
comparatively unknown. GFP is used as a reporter gene, meaning it can be inserted into
the DNA of an organism so that specific cells will express light under certain conditions.
This is a very important tool as it can be used to tag certain genes or cells. For example,
GFP can be inserted so that only those cells expressing a selective trait, such as diseased
cells, will glow. Using this method, exact locations of diseases can be mapped within an
organism. For GFP to express light, an ultraviolet light source must first shine on the
cells. Following the excitation of the cell, the cells containing GFP will emit a greenish
light. Bacterial luciferase has the advantage over GFP of not needing an excitation source
to emit light. The luciferase gene already codes for the fatty acid substrates that act as
fuel and are needed for light emission. The mechanism of GFP has already been
comprehensively researched and mutant proteins discovered, such as Yellow Fluorescent
Protein (YFP) and Blue Fluorescent Protein (BFP). This was accomplished by mutating
the amino acids in the active site of the GFP, a result we hope to reproduce with
luciferase. The Lux Operon is the specific gene that codes for bacterial luciferase and
contains all the genetic material needed to produce functional luciferaseAs mentioned
earlier, the active site of bacterial luciferase is still unidentified but it has been narrowed
down to LuxA, which along with LuxB, are the genes necessary to produce the protein.
Other parts of the lux operon include Lux E, G, C, and D, which code for the substrates
or fuel needed for light emission. By researching and mutating LuxA we hope to find a
modified version of luciferase that will express a different wavelength color, or brighter
intensity.

Aesthetic
In addition to the scientific and medical applications of bioluminescence, there are further
aesthetic purposes for luciferase. The Glowing Plant Project is attempting to take the lux
operon and insert it into plant cells, creating plants that will glow in the dark. If we are
7
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successful in creating a luciferase protein that is brighter or a different color, we will send
our results to the Glowing Plant Project, in hopes that they will be able to use our
mutations of LuxA and insert them into their plants. Another exciting application of
bioluminescence is as a potential light source. The biological mechanism of
bioluminescence is 90% energy efficient, compared to 10% efficiency of standard
incandescent bulbs, meaning almost no energy is wasted as heat. Conceptual ideas
include using bioluminescence in street lighting, bio art, bio-light bulbs, and decorative
purposes. While the light that luciferase produces is still too dim for many of these
applications, we hope to make some of these ideas a possibility by discovering a brighter
or different color mutant of luciferase.

Literature Review
Peat, Scott M., and Byron J. Adams. "Natural Selection on the LuxA Gene of
Bioluminescent Bacteria." Symbiosis 46 (2008): 101-08. Brigham Young University.
This source discusses an experiment in which 31 physiochemical properties were
altered within the luxA gene. They tested for the presence or absence of these
destabilizing selections within the protein structure. This paper is important as it
shows the effect of certain mutations on the luxA gene causing destabilization.
These are areas where our research should most likely avoid mutations.
Tanner, John, Mitchell Miller, Keith Wilson, Shiao-Chun Tu, and Kurt Krause.
"Structure of Bacterial Luciferaseβ2 Homodimer: Implications for Flavin
Binding."Biochemistry 36.4 (1997): 665-72. Web.
This source is an important paper analyzing the function of bacterial luciferase.
The paper explains the different effects of flavin binding in LuxB and expression
levels. This paper helps to explain the binding of LuxB to LuxA including critical
amino acid sites. These are sites that should not be mutated in the mutagenesis
step.
Swartzman, Elana, Shalini Kapoor, Angus Graham, and Edward Meighen. "A New
Vibrio fischerilux Gene Precedes a Bidirectional Termination Site for the lux Operon."
Journal of Bacteriology 172.12 (1990): 6797-802.
This is an old source about the discovery of the luxG gene. Although it is outdated
there is still a lot of good information about the lux operon in terms of secondary
structure and gene sequencing.
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Arnold, Frances Hamilton. and George Georgiou. Directed Evolution Library Creation:
Methods and Protocols. Totowa, NJ: Humana, 2003.

This book has a detailed protocol on how to use error prone PCR to create mutant
libraries. This source is important because it provides a protocol and list of all the
buffers and reagents needed for error prone PCR. Our group is most likely going
to use site directed mutagenesis instead of error prone PCR, however this paper
provides an alternative incase mutagenesis fails/
Loefdahl, Per-Ake. On Bacterial Formats in Protein Library Technology. Stockholm:
Universitetsservice US-AB, 2009.
This source has a detailed description and list of all the current protein
engineering methods used today. This source is important for our project due to
its description of building protein libraries.

Biotechnology Explorer. Ligation and Transformation Module: Instruction Manual. BioRad.
This source is a protocol of how to ligate plasmids into bacterial cells. This will
be important in our project as it will provide us a protocol along with what
reagents and buffers we will need to obtain to perform the ligation.
Engebrecht, Joanne, Kenneth Nealson, and Michael Silverman. "Bacterial
Bioluminescence: Isolation and Genetic Analysis of Functions from Vibrio
Fischeri." Cell 32.3 (1983): 773-81.
This source explains the original isolation of the lux operon from Vibrio fischeri.
This is an old paper so the methods used are not up to date, however it still
provides a background for the rest of our research. In addition, the same plasmid
(pJE202) was used to host the lux operon, giving us information about how to
specifically isolate the lux operon.
Close D, Xu T, Smartt A, Rogers A, Crossley R, et al. (2012) The evolution of the
bacterial luciferase gene cassette (lux) as a real-time bioreporter. Sensors (Basel) 12:
732–752.
This source explains the use of luciferase as a real time bioreporter, one of the
most important uses of luciferase in scientific research. This paper explains the
methods used to isolate luxCDABE, the same genes we will isolate. The specific
plasmids, promoters, and terminators used were explained to create an in vivo
bioreporter gene.
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Critical Analysis

Most of the sources analyzed above are outdated and the techniques no longer used.
While some of the sources provide information about the function of specific amino acids
in the lux operon, the exact active site of bacterial luciferase is still unknown. We will
have to use the known functions of specific amino acids in LuxA, such as the binding site
to LuxB and structural amino sites in the protein, to narrow down which amino acids we
will mutate. The function of these specific amino acids have been discovered as not
responsible for light emission and instead are integral to the overall structure of the
protein. These amino acids will be avoided in our mutagenesis step. In addition, many of
the papers use an outdated technique to insert the DNA into E. coli. We will be using a
more recent and advanced techniques called Overlap extension and Gibson Assembly.
These steps will be explained in detail in the mutagenesis chapter. These new techniques
will shorten and simplify the plasmid design step allowing us to move onto mutagenesis
faster.

Project Goals
Our project aims to find a mutation of the protein luciferase through site directed
mutagenesis that corresponds to a higher intensity or a different wavelength light
emission. We will:

1.

Isolate necessary genes for bioluminescence from the host plasmid (pJE202)

o

Using a series reactions with specific primers we will cut out and isolate
the specific genes of LuxB, LuxCD, and LuxEG from the host plasmid.

2.

Construct our DNA inserts using the isolated genes and insert into E. Coli to
express luciferase.
o

The LuxA gene fragment will be ordered and paired with the previously
isolated LuxB fragment. The LuxCD and LuxEG fragment will also be
joined together in the correct orientation. The two gene fragments of
10
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LuxAB and LuxCDEG will be inserted into E. Coli cells. The E. Coli will
then express luciferase and produce bioluminescence.

3.

Build a mutant plasmid library with mutations at every other amino acid in LuxA

o

Once we have E. Coli cells that successfully express luciferase we can
begin the mutagenesis step. This step will introduce a single amino acid
mutation to LuxA at a time.

4.

Screen cell cultures for desired mutations (intensity of bioluminescence and
wavelength of bioluminescence)
o

Using a plate reader we will measure light intensity and wavelength of
each amino acid change in the protein library. The data will be analyzed to
search for E. Coli colonies that glow brighter or a different wavelength
than the control original luciferase.

5.

Recombine successful mutants to search for further increased bioluminescence or
change in wavelength.
o

The mutants that express luciferase at a different wavelength or greater
intensity will be sent in for exact DNA sequencing.If we have multiple
positive results, the resulting sequences can be recombined to test for
further bioluminescent properties.

We expect to successfully isolate the genes and engineer each of our plasmids so that
luciferase expression can be measured in E. Coli cells. Following this step, we expect
many cells will lose their luciferase expression when the mutations are introduced.
Because proteins are incredibly complex and their interactions still not fully
understood,changing random amino acids is expected to limit or inhibit luciferase
expression. The lux operon has evolved so that luciferase functions at peak efficiency so
it is highly likely that most mutations will destroy the function and perhaps even cause
11
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cell death. We expect to find only one or two successful mutations out of the hundreds of
mutations we will be performing.

Backup Plan
In a project of this size and complexity everything rarely goes as planned, so a backup
plan is necessary. For every step of our project the methods we have chosen to utilizeuse
are not the only option. As an example, if the gene isolation step does not work correctly,
the plasmids can be constructed using restriction enzymes to cut the genes out instead of
PCR primers. The last goal in our project, recombination of successful mutants to find
further mutations, is an optional step that could yield further results but is not necessary
to successfully complete our project. This step is dependent on the success of the steps
before it and so a backup for this step is not necessary. A complete list of project goals
and potential backup plans can be seen in Table 1.

Goal
Isolate Genes

Plan

Backup

PCR reaction with specific

Use restriction enzymes to

primers

isolate gene fragments
(LuxAB/LuxCDEG)

Construct Plasmids

Overlap extension and

Use restriction enzymes for

Gibson Assembly

plasmid construction.

Site directed mutagenesis

Error prone PCR

Screen for desired

Plate reader to test for

Long exposure images of

Mutations

bioluminescence and

cultures followed by ImageJ

wavelength

analysis

Recombine successful

Sequence and

N/A

mutants

recombination of successful

Build Mutant Plasmid
Library

mutants.

Table 1: Overview of major project goals and methods for completion. A backup plan for each goal is
also included in the right hand column.
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Significance
This project has the potential to be very important, as it could help to identify the active
site of luciferase and widen its use as a reporter gene. It is possible that luciferase could
replace GFP for some tasks. GFP is currently so widely used because of its smaller size
and ease of use, but luciferase has the advantage of not needing excitation to emit light. If
a color variant of luciferase were found this would allow multiple assays to be run at the
same time, something already possible with GFP/BFP/YFP.

One of the main driving forces for this project is research for the Glowing Plant Project,
which will introduce the luciferase gene into a plants genome so that it glows. Currently,
the Glowing Plant Project has successfully produced plants that are bioluminescent but
the intensity is still relatively low. By finding a mutant form of luciferase that will glow
brighter, along with different colors of bioluminescence, the Glowing Plant Project will
have a larger variety of products. If our project produces a mutant that is bright enough,
these plants have the potential to act as eco friendly light sources. The seeds could be
shipped to developing countries, and the plants could replace lamps in an eco friendly
and cost efficient manner. Since bacterial luciferase requires no excitation, the plants
would need no other maintenance other than keeping them alive. The potential to replace
light sources that rely on electricity is very exciting especially since the light produced is
heatless and nontoxic.

Team Management
Team management will not be an issue in this project. Since we are a group of two,
coordination has not been an issue. We will be conducting our laboratory research at
Santa Clara University. We both have very similar work ethics and nearly the same class
schedule. This allows for seamless team coordination, which has been a success so far.
The only work that will be performed alone is certain writing assignments. All of the lab
work and project presentations will be conducted as a team with each member doing an
equal part of the work.
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Budget
We will be receiving financial aid from two separate sponsors for our project. Both the
Glowing Plant Project and Santa Clara University will provide funds for our research.
The large majority of the costs for our project are the oligoprimers we will need to order
to perform the mutagenesis step. The Glowing Plant Project has offered to fund this
expensive step, while the funding received from Santa Clara University will cover any
remaining costs. A detailed breakdown of the costs and funding can be seen in Table A-1.

Timeline
In Table A-2a proposed timeline for our progress can be seen. The first subsystem of our
project, plasmid design, will be the most time consuming and complex process. Each
DNA fragment must be correctly isolated and verified before they can be inserted into E.
Coli. Once we have a baseline luciferase expression in our E. Coli cells the mutagenesis
and screening step will be straightforward.

14
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Plasmid Design
A) Introduction-The first major subsystem is to design and create plasmids. A plasmid is
a functional piece of circular DNA that can be inserted into cells.Once inserted into cells,
the plasmid is translated (Translation is the process by which living cells read segments
of RNA and translate it into the corresponding protein product) by the cell in order to
produce proteins. There are 3 major components to a plasmid. The first is an origin of
replication which is necessary for the replication and maintenance of the plasmid in host
cells. The second is an encoded resistance. This resistance is important later on, as it is
used to ensure cells have successfully absorbed the desired plasmid. The third and final
component of a plasmid are the genes you want to study. Every gene has threenecessary
components, a promoter to regulate gene expression, a ribosome binding site (RBS) to
start gene expression, and finally a terminator to let the cell know when to stop
transcription. An outline of the major components and where the come from can be seen
below in Table 2.
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Component

Why is it Important

Source

1) Origin of

Necessary for the replication and maintenance of the plasmid in the Purified

Replication

host cell. Tells the cell how many copies of the plasmid to make.

Plasmid

2) Resistances

Necessary to test for successful plasmid transfection. Plasmids

Purified

encoding for a specific resistance will allow cells to grow in specific Plasmid
antibiotics.
3) Desired Genes

Required genes to carry out the experiment. The genes used in the

Artificial DNA

experiment are LuxA/LuxB/LuxC/LuxD/LuxE/LuxG
-Promoter

Small DNA segment at the start of desired gene, indicated how often Artificial DNA
a gene should be transcribed. Fine tuning weak or strong gene
expression.

-Ribosome Binding

Small DNA segment at the start of desired gene where the ribosome Artificial DNA

Site (RBS)

binds, this is the site where the cell actually starts gene transcription.

-Terminator

Small DNA segment at the end of desired gene, indicates to the cell Artificial DNA
when it should stop transcribing. Very last segment of a gene.

Table 2: Three major components of plasmid DNA. Origin of replication, resistances, and desired genes. Each desired
gene in the plasmid must also contain three components, a promoter, an RBS, and a terminator.

B) Key Constraints - The two major decisions that were necessary to make in order to
design the plasmids were what plasmids to use, and how to assemble our finalized
plasmids. There are hundreds of different plasmids on the market, all containing various
genes, origin of replications and resistances. Since we already knew what genes we were
16
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working with, we wanted a plasmid containing no foreign genes. Resistances also weren’t
a major issue as you they just serve as a test to see if the plasmid was successfully
absorbed by the cells. The decision mostly came down to the origin of replication. We
were looking for plasmids with a fairly high origin of replication, so that our specific
genes would have high expression in our cells.
The other major decision necessary to design our plasmids was how to assemble
our final DNA fragments into one circular plasmid. The traditional way of linking two
pieces of DNA is to use restriction enzyme sites. These sites need to be artificially
designed into every DNA fragment so that they perfectly align and overlap. This requires
a lot more planning and many more reagents. Our mentor however, advised us to use a
brand new technique called Gibson Assembly, which allows for the joining of multiple
DNA segments with no overlapping restriction sites.

C) Detailed Description
1. Essential Genes
2. Choosing the Correct Plasmids
3. Designing the Plasmids
4. Isolating Lux Genes (PCR)
5. Adding Terminators and Promoters (Overlap Extension)
6. Putting the Plasmids Together (Gibson Assembly)

1. Essential Genes - As discussed in the Introduction, the six genes necessary for
light emission of luciferase are LuxA/B/C/D/E/G. LuxA/B code for the actual
luciferase protein, which is what will be mutated in this experiment. In order to
make mutating luciferase easier, LuxA and LuxB will be isolated on their own
plasmid. Not having a very large and complex plasmid with all six of the lux
genes on it will make the mutation process much simpler. The rest of the genes,
LuxC/D/E/G,will be places in a separate plasmid of their own.

2. Choosing the Correct Plasmids - Choosing the correct plasmids is essential, as
the origin of replication for each plasmid determines how many copies of it are in
17
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the cell. Since we are studying a light emitting protein, we want relatively high
copy numbers for both plasmids, so that our product is expressed in high
numbers. The one major concern when choosing plasmids was the ratio of our
LuxAB plasmid to our LuxCDEG plasmid. Since we are mutating LuxAB, we
need to ensure that it always has enough substrate or "fuel" for light emission. It
would be a disaster if we successfully mutated LuxAB, but there wasn't enough
substrate in the cell for luciferase to emit light. Realizing this, we needed to place
LuxCDEG on a higher copy number plasmid than LuxAB. This ensures that there
is always more of the substrate in the cell than the luciferase protein. This
guarantees that any mutants produced will always have enough substrate and light
emission. After talking it over with our advisor he recommended two plasmid,
pBR322 and pACYC177. They are both very common plasmids and are widely
available and well known. pBR322 has an origin of replication with copy number
20. pACYC177 on the other hand has an origin of replication with copy number
15. pACYC177 will contain the genes LuxA and luxB. pBR322 will therefore
contain the genes LuxC, LuxD, LuxE, and LuxG as it has a higher copy number.

3. Designing the Plasmids - After figuring out which plasmids should be used in
our experiment, it was necessary to obtain an exact map of the plasmid. In order
to successfully work with any piece of DNA, you need to know its exact base pair
sequence (consisting of A,C,T,G). Out of the many programs to visualize DNA,
we chose to work with Snapgene and ApE. Snapgene excels at giving users a
visual overview of the plasmid and how it looks as a whole and can be seen in
Figure 2 & 3. ApE on the other hand, specializes in DNA code, the exact
sequence of A's, C's, T's, and G's. The two plasmids we decided to use are well
known, so we had no problem finding and downloading the DNA files online.
Our advisor then sent us the DNA files for our specific genes (LuxABCDEG).
Now that we had the DNA files for our plasmids and our genes, it was possible to
create our finalized plasmids within the computer program. This is an essential
step in the process as it allowed us to visualize the exact genetic make-up of the
plasmids we were creating.
18
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Figure 2: Snapgene file of plasmid DNA pBR322

Figure 3: Snapgene file of plasmid DNA pBR322 with the addition of LuxCDEG.
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4. Isolating Lux Genes - In order to complete our finalized plasmids, it was
necessary to isolate all of the required genes. Our mentor provided us with a
plasmid (pJE202) which contained all of the Lux genes as well as some other
genes which we didn't need. In order to clone the exact genes needed for our
experiment we employed a technique known as polymerase chain reaction (PCR).
This technique allows for the cloning and subsequent amplification of segments
of DNA. By designing forward primers at the start of the gene and reverse
primers at the end of gene, PCR is able to cut out and amplify a specific segment
of DNA. This is demonstrated in Figure 4. The forward and reverse primers were
visualized and designed in ApE. The designed primers are then sent to a company
who synthesizes the exact primers. A detailed description of PCR and the
protocols behind the reaction please visit (14).

Figure 4: Basic overview of polymerase chain reaction (PCR). Through a series of reactions,
template DNA is reacted with forward and reverse primers. These primers effectively ‘sandwich’
the template DNA and amplify the sequence between them

20
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5. Adding Terminators and Promoters (Overlap Extension) - Since we are taking
our genes (LuxABCDEG) from a foreign plasmid, they do not all have the proper
promoters and terminators. As discussed earlier, promoters and terminators are
necessary in regulating gene transcription. Promoters tell a cell how often to
transcribe the downstream genes while terminators tell the cell when the gene
ends. Both are essential in successful gene expression and need to be included in
both of our plasmids. Promoters are typically ~35 base pairs in length while
terminators are typically ~100 base pairs in length. A list of promoters and
terminators can be found at (13). We picked two of the most common promoters
and terminators from this site, they are both very well-known and fully functional.
Knowing the exact base pair sequence of our desired promoter and terminator
allows for incorporation through overlap extension. This process is very similar to
the gene isolation technique described above. Similarly to gene isolation, the
DNA undergoes PCR with forward and reverse primers. The only difference is
that the forward and reverse primers don’t start and end on a specific gene.
Instead, the forward and reverse primers are complements of each other, and will
therefore bind to each other. By ordering primers that have the exact sequence of
the desired promoter and terminator, it is possible to incorporate these new
sequences to the original DNA. The process is easier to comprehend visually as
can be seen in Figure 5.

Figure 5: Overlap Extension. Part A represents the synthetic promoter to be added to the gene
while part B represents the gene itself. Both parts share a small region of overlap which allow them
to bind to each other during PCR.

21

BIOE
6. Putting the Plasmids Together (Gibson Assembly) - The final step of plasmid
design is to assemble all of the acquired DNA sub-units into one final plasmid.
Up to this point we have acquired our genes, acquired our plasmids, isolated the
required genes and incorporated promoters and terminators where necessary. This
results in many small fragments of DNA which need to be assembled into one
final product. The traditional method of joining multiple segments of DNA is by
designing all of the products to contain matching restriction sites. These
restriction sites are chewed back by restriction enzymes and then joined together.
This requires a lot more planning introduces many unnecessary external variables.
In 2009, Dr. Daniel Gibson invented a technique called Gibson Assembly to join
multiple DNA fragments in one single reaction without the need for restriction
enzymes. By designing the DNA inserts to have 15-20 base pairs of overlap,
Gibson assembly can join up to six DNA fragments into one final plasmid product
as can be seen in Figure 6. An in-depth analysis and procedures for Gibson
Assembly can be found on NEB’s website (7)

Figure 6: Gibson Assembly. By designing fragments of DNA to share overlapping regions (A&B),
they are able to be chewed back by T5 Exonuclease to create overhang regions. These
complementary overhang regions are then able to bind to each other to form one final product.
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D) Supporting Analysis and Expected Results - One of the ways to verify our progress
is through the use of gel electrophoresis. After isolating the required genes, it is
possible to run the genes on a gel. This process establishes the presence and length of
a gene product after gene isolation. The basic principle behind this technique is that
and electrical current pulls DNA products through a gel. Smaller products are able to
travel further through the gel as they don’t interfere with gel as much as larger
products. By comparing DNA products to a constant base pair ladder, it is possible to
determine the presence and length of genes, as can be seen in Figure 7.

Figure 7: Gel picture of isolated LuxEG genes. The constant base pair ladder can be seen at the
bottom. LuxEG genes are the four vertical bright bands.

After running all of the isolated genes on a gel, and determining that they are all present
at their correct lengths, the plasmids are assembled through Gibson Assembly. This is
the step that brings every other step together. In order to test if our plasmid products are
23
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fully functional we have to insert them into host E.coli cells. The first test will be to
analyze bioluminescence. If the cells are glowing we know that we have successfully
incorporated all of our genes and can move on to the mutagenesis step. If the cells are not
glowing, it becomes a lengthy troubleshooting process. Since we have two plasmids, the
problem could lie in one of the plasmids or even both of them. To test if the individual
plasmids are functioning we have to test them against their resistances. As discussed
earlier, every plasmid has an inherent resistance coded onto it. Our pACYC177 plasmid
codes for resistance to the antibiotic Kanamycin, while our other plasmid pBR322 codes
for the resistance to the antibiotic Ampicillin. By inserting our plasmids into E.coli host
cells and growing them in media laced with Ampicillin and Kanamycin, it possible to see
which plasmid is functional and which is not. If our cells grow in media+Ampicillin, we
know that our pBR322 plasmid is fully functional. If our cells grow in
media+Kanamycin, we know that our pACYC177 plasmid is fully functional. If they are
unable to grow in any of these media, we know that the cells are not resistant to any of
the antibiotics and both of our plasmids are not functional.

E) Backup Plan - The one step in plasmid design that has a clear backup plan is the final
plasmid assembly. As discussed earlier, the traditional method of joining multiple
segments of DNA is through restriction sites. If we hit a brick wall in our attempt to join
our DNA through Gibson Assembly, we can fall back to joining them through restriction
sites. For all of our other experimental steps, including Gibson Assembly, we will need to
trouble shoot the experiment by repeating it many times, changing a single parameter
each time. The best way to troubleshoot experiments is to seek advice from people who
have had success with the experiment. Since many of our professor’s and senior design
advisor have been able to successfully complete most of the experiments outlined in the
plasmid design section, we will look to them for help in tweaking our experiments until
they yield positive results.
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Mutagenesis
A) Introduction - The basis of all genetic engineering stems from the central dogma of
biology. This idea is that DNA codes for amino acids which are the building blocks of
proteins. By changing the DNA sequence, you change the amino acid sequence, which
changes the final protein product. Ultimately we are trying to mutate luciferase which is a
protein. Attempting to isolate a protein and manually change its sequence without the
help of cellular machinery is extremely complex. The easiest method of mutating proteins
is to start at the DNA level and then having living cells translate the mutated protein for
you. This is the method we will be utilizing for our protein mutagenesis process.

B) Key Constraints - When it comes to mutating DNA there are dozens of techniques.
Three of the most prevalent techniques utilized in today's industry are error-prone PCR,
combinatorial mutagenesis, and site-directed mutagenesis. Error-prone PCR, or ePCR for
short, is a random mutagenesis method that utilizes PCR, the experimental method
discussed earlier. The DNA involved is the same as regular PCR, you need your template
DNA (DNA you want to mutate) and forward and reverse primers that flank your
template DNA on both ends. The only difference is that during ePCR, the reaction
conditions are changed. This can be accomplished by using less efficient polymerases or
adding Mn2+ ions to the solution. By offsetting the ideal PCR conditions the DNA
translation is disrupted and random mutations occur. This technique is very random and
can mutate the same spot over and over. There is no real control on where and how many
mutations are made. Sometimes dozens of mutations are made in one reaction which will
almost always disrupt protein function.
One of the most popular and effective techniques to DNA mutation is combinatorial
mutagenesis. This technique however requires two proteins for mutagenesis. The proteins
need to be fairly similar to each other as well. The proteins are essentially spliced and
mixed and put back together. The final product is a mixture of proteins which are
combinations of the two parent proteins. This technique offers a quick and easy way to
produce a library of mutant proteins. This technique is not appropriate for our project
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because it doesn't reveal anything about the parent protein. Since we are trying to study
one specific type of luciferase, it doesn't make sense to create an alternate protein that is
only half of the original luciferase. In order to actually reveal the secrets and potential
active site of luciferase, it is important we maintain our mutant proteins as close to the
original as possible.

C) Detailed Description - The technique we have chosen to mutate our protein is called
site-directed mutagenesis. This technique allows for the mutation of single sites within
the protein and is very controlled and methodical. Once again, this technique uses the
basic principles of PCR. You need template DNA and forward and primers. Primers
typically exactly match the sequence of the template you want them to bind to. During
site-directed mutagenesis you purposefully incorporate single changes in the primers.
These single changes are located in the center of the primers, and are flanked by 10-15
base pairs of correct sequence on both sides. These single point mutations don't disrupt
proper primer binding as they still match the original DNA sequence everywhere else as
can be seen in Figure 8. This technique allows for the mutation of specific sites. The rest
of the DNA stays exactly the same except for one single change which is introduced. This
allows for methodical mutation as you can mutate each and every point of the protein and
study the effect of that one mutation.

The drawback of this technique is that it is very time and money consuming. Every single
mutations site needs to have its own primers and be run in its own test tube. In order to
analyze the entire luciferase protein would cost over $5,000 and would take weeks of
rigorous lab work to complete. Research of literature has given us some clues as to what
sites to begin mutating. The very end of LuxA, where it binds to LuxB has been
determined to not have a significant contribution to its bioluminescence. We will
therefore steer clear of this region. There are also a few other small regions of the protein
that are thought to be responsible for protein structure and not protein function. Because
nobody knows exactly what part of the protein is responsible for light emission, it is a
guessing game for which sites to mutate. We will mutate the sites we believe are most
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likely to yield successful mutations until we run out of money or time, whichever comes
first.

Figure 8: Site-directed mutagenesis. Original DNA is shown on the bottom strand. The
primer is located on the top. The primer perfectly matches original DNA except for one
mutation site located at the center.

D) Supporting Analyses and Expected Results - In order to determine if we have
successfully mutated our DNA and therefore proteins, we will need to analyze them in a
screening process which is the last and final step of our project. The details of this step
are covered in the screening chapter. The basic idea is that after mutating our DNA we
will insert the plasmids into E.coli cells and have them produce our mutant proteins. We
will analyze the E.coli for changes in bioluminescent properties. If screening doesn't
yield any successful mutants we will go back to mutation and create more mutants to
analyze. This step is closely intertwined with screening, as it becomes a constant cycle of
creating mutants, and then analyzing them.
If we really hit a brick wall and aren't finding any mutant proteins we can get our DNA
sequenced. After performing mutagenesis, we can send our product out to a company
who can analyze it and tell us the exact base pair (A,C,T,G) sequence of our sample. That
way we can figure out if we were able to successfully mutate the DNA and the proteins
just aren't functional, or if our mutagenesis step went awry.
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E) Backup Plan - As discussed earlier, there are many forms of mutating DNA. If we are
having trouble with site-directed mutagenesis, we can switch to error-prone PCR or even
recombine our protein with another protein through combinatorial mutagenesis. As with
every other part of this project, the experimental procedures are very sensitive and will
require a lot of work and tweaking to get just right.
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Screening
A) Introduction - The screening subsystem of our project is the final step and will be
used to quantitatively and qualitatively measure the success of our mutations. This is the
most straightforward of the three steps, and will have two distinct parts: a quantitative
and qualitative step. We will be testing the mutant colonies from the mutagenesis step for
any form of bioluminescence. The quantitative step will be performed by our group and
involves hand-picking colonies that show any bioluminescence. Any cells that express
light will be picked and harvested. After picking, the glowing cells will be placed in a
plate reader which will quantitatively measure the wavelength and light intensity from
each cell colony. We will have a benchmark value for bioluminescence from our original
un-mutated cells of both wavelength and intensity. By comparing the wavelength and
light intensity of our mutants to the benchmark values, we will be able to ascertain if our
mutations were successful.

B) Key Constraints - The light emitted from the bioluminescent cells is very low
intensity so our group must be careful and precise to obtain our quantitative data. The
device we use will have to be very sensitive in order to pick up differences in light
intensity and wavelength, given that the benchmark data will be very low intensity. We
will be using the Tecan Infinite 200 Pro plate reader on the glow luminescence setting to
obtain our data. Because the light that is emitted from the cells is very weak and we have
hundreds of colonies to screen we decided to use the plate reader over taking long
exposure images and doing image analysis. This will greatly speed up the screening step
and will save our group many hours of image analysis. In addition, by keeping the
quantitative screening step consistent we will be able to compare our data of wavelength
and intensity across all of our cell colonies.

C) Design Description - It will be important to have a clear benchmark for intensity and
wavelength to compare the rest of our data to. This step will be done once we have
completed the plasmid design and have successfully introduced our plasmids into the E.
Coli cells. To keep our data consistent we will use the plate reader to obtain an average
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wavelength and light intensity for a given cell colony. The cells measured for the
benchmark will have to be counted using a hemocytometer so we can obtain a value that
is proportional to the cell number. Because each well in the plate reader will not have the
same number of cells the intensity will differ from well to well. Therefore, it is important
that we compare our light intensity values to the number of cells in each well. Finally we
will obtain a value of lumens per cell, which we will then use to compare the positive
results from the mutagenesis step.

Following the mutagenesis step, cells will be grown for 12-14 hours in 96 well plates. In
a dark room, the plates will be hand screened for colonies that exhibit bioluminescence.
Any wells that contain glowing cell colonies will be successful mutants. These colonies
will be labeled, counted, and then screened using the plate reader to obtain values of
wavelength and light intensity per cell. These values can be compared to the benchmark
values to gauge if the mutant cells have a greater intensity or any significant change in
wavelength.

D) Expected Results - The bacterial luciferase protein has evolved to perform at peak
efficiency so it is expected that the great majority of mutations will disrupt the overall
function of the protein rather than alter it. Therefore, we expect that the majority of our
mutations will completely stop bioluminescence or weaken it significantly. However, out
of the 300 mutations we anticipate that one or two will produce either a significant
change in wavelength of greater than 100nm shift or a greater intensity. The peak
wavelength for bacterial luciferase is recorded around 490nm,a bluish-green light, and we
expect our benchmark results to be within 15nm. Following this data, we will compare all
positively screened mutants from the qualitative step in terms of wavelength and
intensity. Finally, mutants that have passed the qualitative step will be sent in for
sequencing. We expect only one or two colonies of the hundreds of mutations will be
successful.
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E) Backup Plan - In case the plate reader malfunctions or is not sensitive enough to
measure small differences in wavelength or intensity, we will have access to a high
quality camera and tripod. We can use this setup to take long exposure images of our cell
plates and measure intensity and wavelength using image analysis. The program ImageJ
can be used to perform image analysis on these images. The process would be much more
time consuming and would greatly slow down the progress of our project. Each 96 well
plate would have to be analyzed for intensity and each of the 96 wells done individually.

Materials and Methods

DNA
Lux Operon-The Lux Operon DNA was obtained in plasmid form (pJE202) from
Biocurious.

PCR Primers-- All primers used in the PCR were custom ordered from Elim Biopharm.
The primers were resuspended in 75µL ddH20 and concentration measured (ng/µL) via
nanodropper(Thermo Scientific Nanodrop 2000). These primers were diluted to 1550ng/µL and later used in PCR.

Plasmids-- pACYC177 and pBR322 were ordered from New England Biolabs. The
pACYC177 plasmid was obtained in an E. coli strain (ER2420). A plasmid DNA
extraction procedure was run to isolate the pACYC177 plasmid.

Protocols

Transformation into E. coli Cells (Plasmid Amplification)
1. Thaw E. coli cells on ice for 5-10 minutes
2. Transfer 2µLof plasmid DNA into the 50 µL aliquot of E. coli cells. Incubate
transformation reaction on ice for 30 minutes.
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3. Heat shock the transformation for 30 seconds at 42°Cand then place
transformation on ice for 2 minutes.
4. Add 500 µL LB Media and incubate the transformation at 37°C for 60 minutes
with shaking at 225 RPM.
5. Plate 50 µL of the incubated solution onto (+)Ampicillin resistant LB-agar plate.
Incubate overnight for 12-16 hours at 37°C.
6. Pick 4 different colonies from plate and insert into 5mL LB/5µL Ampicillin
solution. Culture overnight for 14-15 hours at 37°C.

Extraction of Plasmid DNA from E. coli Cells (Qiagen Mini Plus Plasmid DNA
Extraction System)
1. Pellet 1-5mL bacterial overnight cultures by centrifuging at >8000 rpm for 3 min
at room temperature.
2. Resuspend pelleted bacterial cells in 250µL Buffer P1 and transfer to a
microcentrifuge tube.
3. Add 250µL buffer P2 and mix thoroughly by inverting the tube 4-6 times until the
solution becomes clear. Do not allow the lysis reation to proceed for more than 5
min. If using LyseBlue reagent the solution will turn blue.
4. Add 350µL Buffer N3 and mix immediately and thoroughly by inverting the tube
4-6 times. If using Lyse Blue, the solution will turn colorless.
5. Centrifuge for 10 min at 13,000rpm in a table-top centrifuge.
6. Apply the supernatant from step 5 to the QIAprep spin column by decanting for
pipetting. Centrifuge at 9000rpm for 30-60 sec and discard the flow-through.
7. Wash the QIAprep spin column by adding 750µL buffer PE. Centrifuge at
9000rpm for 30-60s and discard the flow-through.
8. Centrifuge at 13,000rpm for 1 min to remove residual wash buffer.
9. Place the QIAprep column in a clean 1.5 mL microcentrifuge tube. To elute the
DNA, add 50µL ddH20 to the center of the QIAprep spin column. Let stand for 1
min, then centrifuge at 13,000rpm for 1 min.
10. Use nanodropper to drop 1µL of and determine concentration in ng/µL.
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Polymerase Chain Reaction (PCR) Procedure (Eppendorf Mastercycler Gradient
Machine):
1. The following reaction is set up in a micro centrifuge tube.

Reaction
Template DNA
Forward-Primer (Elim Biopharm)
Reverse-Primer (Elim Biopharm)
Taq Polymerase (Promega)
dNTP’s
10x Buffer (New England Biolabs)
ddH20
Total:

Amount
50ng
100ng
100ng
1µL
2µL
10µL
X µL
100µL

2. 100µL PCR reaction mix was split into two 50µL reaction tubes and placed into
Thermocycler (Eppendorf Mastercycler)
Program:
1. T=98.0°C 0:00:30
2. T=98.0°C 0:00:10
3. T=58.0°C 0:00:35
4. T=72.0°C 0:02:10*
5. GoTo 2 REP 29
6.T=72.0°C 0:10:00
7. HOLD 4.0°C
*The time for step 4 was determined by the length of DNA fragment being
extracted (1000bp/min). For example 0:02:10 = 2100bp.
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Gel Electrophoresis Procedure
We used a 0.8% agarose gel mixture for all gel experiments.
1. Add 0.4g of agarose to 50mL1X TAE Buffer in Erlenmeyer flask for 0.8%
agarose gel mixture.
2. Microwave for 30 seconds or until mixture was boiling.
3. Let mixture cool and add 2.5µL of Ethidium Bromide to agarose gel mixture.
4. Add 10µL of the loading dye (Invitrogen DNA Stain) to each 50µL PCR sample.
5. Pour gel in mold and let mixture cool until it hardens.
6. Add 30µL of PCR reaction into each well along with 7µL of 1Kb ladder (Alfa
Aesar DNA Marker High Range 1Kb-10Kb)
7. Run gel at a constant voltage of 120V for 30min at 400mA.
8. View gel with UV light source and take screenshot.
Gel Extraction (Qiagen)
1.
2.
3.
4.
5.

6.
7.
8.
9.

Cut out gel fragment containing DNA bands.
Weigh the gel fragment. Add 3 volumes of QG buffer to 1 volume gel. (1g=1mL)
Incubate at 50°C for 10 min. Vortex every 2-3 min to help gel dissolve.
Add 1 Volume isopropanol (1g=1mL)
Place in spin column and centrifuge for 1 min at 9,000 rpm. Discard flowthrough
and place column in the same tube. If reaction is >800µL, keep adding and
centrifuging until it has all be spun through.
Add 750µL PE Buffer to column and centrifuge at 9,000rpm for 1 min. Discard
flowthrough.
Centrifuge at 9,000rpm in 2mL collection tube for 1 min to remove residual wash
buffer.
Place in clean 1.5mL centrifuge tube.
To elute DNA, add 30µL ddH20 to center of column and centrifuge for 1 min.

Gibson Assembly (New England Biolabs)
1. Set up on Ice:
Reaction
PCR Fragments+ Linearized Vector
Gibson Assembly Master Mix
ddH20
Total Volume:

Volume Amount
(XµL)(0.02-0.5pmols*)
(10µL)
(10-XµL)
20µL

*pmols=(weight in ng) x 1,000/(basepairs x 650 daltons)
2.

Incubate mix at 50°C for 60min.
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Results
Our project is difficult to show results for, as each step in the project can’t be physically
seen. There are two main methods we used to obtain results and make sure that our steps
were working. Gel electrophoresis allowed us to verify and confirm that our PCR steps
worked correctly. These were integral in making sure that the DNA segments that we cut
out were the correct size and the DNA that we wanted. The second method was
transfecting E. coli cells a plasmid containing a certain antibiotic resistance encoded into
it. If E. coli containing our plasmids were able to grow on the antibiotic LB plate, then
the plasmid must be fully functional.

The first step in our project was to amplify the pJE202 plasmid obtained from
Biocurious. After following the transformation and plasmid extraction protocols, we
achieved a final DNA concentration of 26.2ng/µLfor our pJE202 plasmid. Following this
step we designed primers to cut out each of our DNA fragment subsections, LuxAB,
LuxCD, and LuxEG. The pJE202 plasmid served as the template DNA for each of the
PCR reactions. The results from our PCR DNA extraction step can be seen in the gel
images shown in Figures 9-11. As seen in Figure 10a, PCR can produce errors for a
variety of reasons. The experiment was repeated with the same primers, PCR conditions,
and template DNA. Figure 10b shows that the LuxCD fragment was successfully
obtained and verified.

Following the isolation and verification of each of our DNA fragments the next step was
to prepare each piece for Gibson Assembly. The new plasmids (pACYC177, pBR322)
were linearized using custom ordered PCR primers that cut open the plasmid in certain
sections. The linearized plasmids were gel verified and stored until each fragment was
ready. LuxCD, LuxEG, and Lux AB also had to be prepared for Gibson Assembly. The
15-20bp overlap between each fragments in critical to Gibson Assembly, so these
sections had to be added to each of the fragments. This was done using a method called
overlap extension. Overlap extension is a PCR with specific primers that elongate the
template DNA. We performed overlap extension on each of our 3 DNA fragments, but
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since the fragment is only being elongated by 15-20bp, these were not able to be gel
verified. The difference between a DNA fragment that is 2000bp and 2015bp would be
indistinguishable on a gel. Instead, we assumed that the PCR worked correctly for each of
these fragments and moved on to the next step: Gibson Assembly. We ran the Gibson
Assembly protocol for each of our plasmids and DNA fragments (LuxAB-pACYC177,
LuxCD/LuxEG-pBR322) and then transformed them into E. coli cells and grew them on
seperate antibiotic LB plates. The cells containing pACYC177 was grown on a
Kanamycin (+Kan) plate, because pACYC177 contains the Kanamycin resistance. The
cells containing pBR322 were grown on an Ampicillin (+Amp) plate, because pBR322
contains Ampicillin resistance. The results can be seen in Figure 12. The cells containing
the pACYC177 plasmid did not grow, while growth can be seen in the pBR322
containing E. coli.

Figure 9. Gel of LuxAB DNA fragments. The 4 bright bands correspond to the DNA
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A
Figure 10. A) Gel of LuxCD DNA fragments. Only 2 out of 4 bands can be seen, indicating a problem
with the PCR. The bands are also slightly offset corresponding to different sizes of DNA fragments.
B) Gel of LuxCD DNA fragments. All 4 bands can be seen in this gel corresponding to a successful
PCR and gene extraction.
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Figure 11. Gel of LuxEG DNA fragments. The 4 bright bands are directly beneath the
2,000bp ladder as expected. The image is colorized because it was taken with a different
camera.

Figure 12. Plates showing the growth of e. Coli after plasmid has been
transfected into the cells. pACYC177 was grown on a +Kan plate and pBR322
on a +Amp plate.
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Discussion
The results obtained over the course of this project were all expected. It took a few weeks
of troubleshooting to get all of the experiments up and running, but once we were
familiar with the experimental procedures, the results obtained were all expected. The
DNA fragments we were able to isolate through PCR extraction were all the expected
lengths. By running the gels we are able to confirm that our PCR reactions were able to
successfully isolate the correct length and therefore sequence of DNA. The successful
creation of our pBR322 plasmid proves without a doubt that we were successful in
isolating and creating overlap between our Lux CD, Lux EG, and linearized pBR322
fragments. The other plasmid, pACYC177 did not yield a functional plasmid, some
possible reasons for this are discussed below.

The successful creation of one our plasmids but not the other provides very essential
feedback. This proves that we were able to successfully set up and carry out Gibson
Assembly in order to join our DNA fragments into one finalized plasmid. This provides
valuable insight as we can be confident that our overall experimental system is
functional, and only certain parameters that differ between the two experiments need to
be tampered with. One of the biggest concerns we had as to why our pBR322 plasmid
came out functional and our pACYC177 plasmid did not is that our DNA concentrations
for pACYC177 were substantially lower. The Lux AB fragment used in our Gibson
reaction was at a substantially lower concentration that the rest of our DNA. This
required that we dilute the rest of our DNA in order to achieve equal concentration of
DNA for the Gibson reaction. This mass dilution of our DNA and small final
concentrations of product could have led to our experiment going awry.

Another possible suggestion is that some of our overlap extension reactions did not run to
completion. There is no way for us to check if we have successfully completed overlap
extension on our budget. The small 30 base pair overlap regions introduced by overlap
extension are not long enough to be visualized by gel electrophoresis like our other
39

BIOE
~2000 base pair fragments. If overlap extension wasn't successful on any of the DNA
fragments, then the whole Gibson reaction would not yield any results.

In order to try to run a successful Gibson reaction for our pACYC177 plasmid, we have
to essentially re-isolate the DNA and run overlap extension over. This isn't too much of
an issue as we still have all of the reagents from the first round of experiments and have
all of the experimental procedures down to an art. This will allow us to achieve higher
concentrations of our Lux AB fragment as well as redo our overlap extension. By redoing
the experiments for our pACYC177 plasmid leading up to Gibson we can both obtain
higher concentrations of our Lux AB fragment as well as redo our overlap extension.
These two parameter should allow the successful creation of our pBR322 plasmid. With
this plasmid made, we can insert both of the plasmids into cells and start the mutagenesis
portion of our project.

Conclusion
The overall goal of this project was to setup a genetic system for the expression of a
bioluminescent protein luciferase, and then mutate this system in order to enhance
bioluminescent properties. To set up this bioluminescent system, we first needed to
isolate all of the genes necessary for bioluminescence. These six genes came in pairs of
two, LuxAB, LuxEG, and Lux CD. Once the genes were isolated it was necessary to put
them back together into two final plasmids. These plasmids required custom promoters
and terminators which we constructed from synthesized primers. Once the two plasmid
system is in place we can begin to mutate and screen for desirable mutant proteins. We
have successfully isolated all of the DNA necessary to make both of our plasmids, and
successfully synthesized our pBR322 plasmid.
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Project Objective

Complete

In
Progress

Future
Work

DNA Isolation
Lux CD
Lux EG
Lux AB
Linearized pACYC177
Linearized pBR322
Promoter/Terminator Construction
pBR322 Promoter
pACYC177 Promoter
pACYC177 Terminator
Gibson Assembly
Complete pBR322 Plasmid
Complete pACYC177 Plasmid
Mutagenesis
Screening
Table 3. Completion and progress of milestone steps.

The most time consuming and difficult portion of this project was to create a plasmid
from scratch. Mutating a protein is fairly simple, and is a matter of money and time. The
real challenge in this project was to isolate specific genes and then put them back
together so a cell could read the DNA and produce proteins. We were able to isolate all of
the DNA fragments necessary for bioluminescence and verify them through gel
electrophoresis. These isolated DNA fragments then had to put back together into one
final plasmid. This requires that each fragment contains overlap with the other fragments,
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which is very hard to verify. By successfully creating one of our plasmids we are able to
prove that we were able to introduce the correct overlap between the fragments and
successfully carry out the Gibson Assembly reaction. The other plasmid was not
successful, and we are working to get the experiment just right for this plasmid. The
important thing is that we were able to successfully create one plasmid, so the other
should just require small experimental tweaks. Once we have been able to successfully
create our other plasmid we will have obtained bioluminescence and can start mutating
the DNA.

Once we have both of our finalized plasmids, we can begin to mutate Lux A and look for
mutant proteins. This mutation process involves the same experimental techniques as our
gene extraction. The mutation is a matter of time and money and likely won't pose any
experimental hardships. Once we have mutated our Lux A DNA we will insert it into
E.Coli cells and have them express our mutated proteins for us. We will then screen these
mutated proteins to look for any desirable bioluminescent properties.
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Appendix
A-1 Budget

Item

Cost

Paid By

Oligos Plates (Primers)

$500-2000

Glowing Plant Project

pBR322 Plasmid

$100

SCU Aid

pACYC Plasmid

$0

SCU Aid

PCR Primers

$200-300

SCU Aid

Codon Optimized LuxA

$300

SCU Aid

Qiagen Mini-Prep Kit

$80

Required

SCU Aid
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